Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection

European Respiratory Journal

Volumn 13, Issue 6, 1999, Pages 1371-1379

  Nakamura, H ^a   Fujishima, S ^a   Inoue, T ^a   Ohkubo, Y ^a   Soejima, K ^a   Waki, Y ^a   Mori, M ^a   Urano, T ^a   Sakamaki, F ^a   Tasaka, S ^a   Ishizaka, A ^a   Kanazawa, M ^a   Yamaguchi, K ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Chronic lower respiratory tract; Infections; Interleukin 8; Leukotriene B4; Neutrophil elastase; Roxithromycin

Indexed keywords

INTERLEUKIN 8; LEUKOCYTE ELASTASE; LEUKOTRIENE B4; MACROLIDE; ROXITHROMYCIN;

ANTIBIOTIC THERAPY; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; IMMUNOREGULATION; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; MEDIATOR RELEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; VITAL CAPACITY;

ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; BRONCHIOLITIS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOTACTIC FACTORS; CHRONIC DISEASE; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-8; LEUKOCYTE ELASTASE; LEUKOTRIENE B4; MACROPHAGES, ALVEOLAR; MIDDLE AGED; NEUTROPHILS; OXYGEN; RESPIRATORY TRACT INFECTIONS; ROXITHROMYCIN; VITAL CAPACITY;

EID: 0032792527     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.13f23.x     Document Type: Article

References (34)

1. Ichikawa Y, Nimomiya H, Koga H, et al. Erythromycin reduces neutrophils and neutrophil derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis 1992; 146: 196-203.
2. Kadota J, Sakito O, Kohno S, et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993; 147: 153-159.
3. Nagai H, Shishido H, Yoneda R, Yamaguchi E, Tamura A, Kurashima A. Long-term low dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 1991; 58: 145-149.
4. Fitzgerald JE, King TE Jr, Lynch DA, Tuder RM, Schwarz MI. Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med 1996; 154: 497-503.
5. Oda H, Kadota J, Kohno S, Hara K. Erythromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchiolitis. Chest 1994; 106: 1116-1123.
6. Umeki S. Anti-inflammatory action of erythromycin: its inhibitory effect on neutrophil NADPH oxidase activity. Chest 1993; 104: 1191-1193.
7. Oishi K, Sonoda F, Kobayashi S, et al. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect Immun 1994; 62: 4145-4152.
8. 1-proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am Rev Respir Dis 1993; 148: 1665-1670.
9. 4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. Am Rev Respir Dis 1993; 148: 896-901.
10. Sakito O, Kadota J, Kohno S, Abe K, Shirai R, Hara K. Interleukin 1β, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration 1996; 63: 42-48.
11. Matsushima K, Morishita K, Yoshimura T, et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MD-NCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 1988; 167: 1883-1893.
12. Einer VM, Strieter RM, Elner SG, Baggiolini M, Lindley I, Kunkel SL. Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am J Pathol 1990; 136: 745-750.
13. Fujishima S, Hoffman AR, Vu T, et al. Regulation of neutrophil interleukin-8 gene expression and protein secretion by LPS, TNFα, and IL-1β. J Cell Physiol 1993; 154: 478-485.
14. 4 stimulates human polymorphonuclear leukocytes to synthesize and release interleukin-8 in vitro. Am J Respir Cell Mol Biol 1994; 10: 651-657.
15. Nakamura H, Yoshimura K, McElvaney NG, Crystal RG. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest 1992; 89: 1478-1484.
16. Konno S, Adachi M, Asano K, Kawazoe T, Okamoto K, Takahashi T. Influences of roxithromycin on cell-mediated immune responses. Life Sci 1992; 51: 107-112.
17. The BAL Cooperative Group Steering Comittee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 1990; 141: 169-202.
18. Nakamura H, Fujishima S, Waki Y, et al. Priming of alveolar macrophages for interleukin-8 production in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 152: 1579-1586.
19. Rennard SI, Basset G, Lecossier D, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986; 60: 532-538.
20. Poupard JA, Dewees LB, Morton HE. Antibiotic susceptibility of Klebsiella enterobacter as determined by a single high-concentration disc method. Antimicrob Agents Chemother 1969; 9: 489-494.
21. Munoz C, Misset B, Fitting C, Bleriot JP, Carlet J, Cavaillon JM. Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J Immunol 1991; 21: 2177-2184.
22. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 1982; 125: 332-337.
23. Nakamura H, Yoshimura K, Jaffe HA, Crystal RG. Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem 1991; 266: 19611-19617.
24. Thelen M, Peveri P, Kernen P, Von Tscarner V, Waltz A, Baggiolini M. Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J 1988; 2: 2702-2706.
25. 4, potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980; 286: 264-265.
26. Hand WL, King-Thompson NL. Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity. Antimicrob Agents Chemother 1986; 29: 135-140.
27. Stamler DA, Edelstein MAC, Edelstein PH. Azithromycin pharmacokinetics and intracellular concentrations in Legionellapneumophila-infected and uninfected guinea pigs and their alveolar macrophages. Antimicrob Agents Chemother 1994; 38: 217-222.
28. Hand WL, King-Thompson N, Holman JW. Entry of roxithromycin (RU 965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1987; 31: 1553-1557.
29. Carlier M, Zenebergh A, Tulkens PM. Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells. J Antimicrobial Chemotherapy 1987; 20: 47-56.
30. Yasuda H, Ajiki Y, Koga T, Kawada H, Yokota T. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother 1993; 37: 1749-1755.
31. Takeyama K, Tamaoki J, Chiyotani A, Tagaya E, Konno K. Effect of macrolide antibiotics on ciliary motility in rabbit airway epithelium in vitro. J Pharm Pharmacol 1993; 45: 756-758.
32. Tamaoki J, Isono K, Sakai N, Kanemura T, Konno K. Erythromycin inhibits Cl secretion across canine tracheal epithelial cells. Eur Respir J 1992; 5: 234-238.
33. Fujishima S, Sasaki J, Shinozawa Y, Takuma K, Hori S, Aikawa N. Interleukin 8 in ARDS. Lancet 1993; 342: 237-238.
34. Konno S, Asano K, Kurokawa M, Ikeda K, Okamoto K, Adachi M. Antiasthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo. Int Arch Allergy Immunol 1994; 105: 308-316.